Panel Discussion: How Clinical Confidence & Scalability Shape the Future of CNS Drug Delivery

Time: 3:15 pm
day: Day Two - Afternoon

Details:

• Explore how investors evaluate risk and opportunity in a space where strong science must meet real-world viability
• Examine how clinical or translational validation – from receptor engagement to dose modeling – influences investor confidence in CNS delivery platforms
• Discuss how manufacturability, scalability, and delivery route compatibility affect long-term viability and funding decisions
• Understand the importance of mechanism clarity, receptor strategy, and IP positioning in shaping perceived value and freedom to operate

Speakers:

Iwona Ziomkiewicz Iwona Ziomkiewicz, PhD, is Drug Discovery Manager at Parkinson’s UK’s Virtual Biotech, the venture philanthropy initiative accelerating the development of new treatments for Parkinson’s disease. Read more